[Rifampin].
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D003090:Coliphages / Q000187:drug effects; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004926:Escherichia coli / Q000187:drug effects; D005827:Genetics, Microbial; D051379:Mice; D008933:Mitochondrial Swelling; D009154:Mutation; D009858:Oncogenic Viruses / Q000187:drug effects; D012313:RNA / Q000037:antagonists & inhibitors; D012328:RNA Viruses / Q000187:drug effects; D012293:Rifampin / Q000096:biosynthesis / Q000494:pharmacology; D012294:Rifamycins / Q000378:metabolism; D013210:Staphylococcus / Q000187:drug effects; D013302:Streptomyces / Q000378:metabolism
D012294:Rifamycins; D012313:RNA; D012321:DNA-Directed RNA Polymerases; D012293:Rifampin
Ryfampina.